Navigation Links
Neurocrine Announces Work Force Restructuring
Date:12/13/2007

SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today staff reductions of approximately 130 employees at its San Diego campus, as a part of its restructuring program to prioritize its research and development programs and associated costs and expenses after the setback on indiplon. Following these reductions, Neurocrine will have approximately 120 employees.

"It is with great disappointment that we have to make this difficult decision that will have such an effect on so many of our employees and their families. We are greatly saddened to move in this direction after our employees have continually demonstrated only the highest level of dedication and commitment. However, in order to meet our goals on other high priority programs, we have to refocus our resources as quickly as possible. I want to sincerely thank the departing employees for their tremendous efforts and wish them great success in the future," said Gary Lyons President & CEO. "We will maintain our focus on determining the path forward with indiplon after interactions with the FDA, and our efforts on GnRH, as we move expeditiously toward partnering this program. We will also continue with focused research and development efforts aimed at treating diseases of the central nervous and endocrine systems. We intend to continue to conservatively manage our cash resources and review collaborative alternatives to fund the advancement of our pipeline."

The Company is preparing a formal meeting request to the FDA to discuss the 2007 Approvable Letter. We have notified FDA that we would be submitting this formal request.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
2. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
3. Neurocrine Biosciences to Present at the Bear Stearns Healthcare Conference
4. Neurocrine Biosciences to Present at the A.G. Edwards Annual Emerging Growth Conference
5. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2007 Financial Results
7. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
8. Neurocrine Biosciences Announces Conference Call and Webcast to Provide Indiplon Update
9. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... 2013 The paradigm of ‘one drug, ... that can help predict the adverse and therapeutic effects ... Head of Computational Biology at the Genomics Laboratory, Covance, ... ensure high-quality genomics when used as part of the ... complex data sets to identify key clinical targets even ...
(Date:5/17/2013)... 2013 Rust removal is one of home ... items could be damaged. To help rust contractors make it ... no-scrubbing rust remover it called Rusterizer. It announced ... 10% discount. , My Cleaning Products explained that rust could ... by staining them. The first one, it said, happens ...
(Date:5/17/2013)... Tooth decay is an epidemic in American children with 50% ... World Health Organization says that worldwide, 60–90% of ... are the long-term effects of this transmissible infection? , ... oral bacterial imbalance and serious systemic issues like heart disease. ... also 100% preventable? Answer: there has been no way to ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... to be Used for Advancement of Cancer Stem Cells and Other ... ... MacroGenics, Inc., a privately,held biotechnology company that develops immunotherapeutics to treat,autoimmune ... million in a Series D-2 financing. The round, led by,Nextech Venture, ...
... COLLINS, Colo., Sept. 24 InVitria,( http://www.InVitria.com ... Annual "Optimizing Cell Culture Development" Conference on,September ... most recent,results optimizing cell culture media using ... ingredients.,( http://www.healthtech.com/ocb/overview.aspx?c=562 ), In a presentation ...
... combats an,alarming rise in chronic diseases, the Pharmaceutical ... new report on the next,generation of medicines in ... The report found that America,s pharmaceutical research ... - are,testing a record 633 new biotech medicines., ...
Cached Biology Technology:MacroGenics Raises $25M in Series D-2 Financing 2MacroGenics Raises $25M in Series D-2 Financing 3MacroGenics Raises $25M in Series D-2 Financing 4InVitria Touts Product Advantages at Cambridge's Cell Culture Conference 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 3
(Date:5/17/2013)... By day, insects provide the white noise of the South, ... typical year, the Southern air hangs heavy from the humidity ... to more than 140 species of frogs, toads and salamanders, ... If the ponds and swamps are the auditorium for their ... Research and Monitoring Initiative, or ARMI, have front-row seats. ...
(Date:5/17/2013)... (Intelligent Cargo in Efficient and Sustainable Global Logistics Operations) ... improvement in the efficiency of intermodal loading systems and ... It comprises 29 European organisations with experience in the ... a budget totalling 17,000,000 and a duration of three ... specify and develop the semantic components and ontologies shared ...
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
Breaking Biology News(10 mins):Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4New logistics services that will cut energy consumption and CO2 emissions 2
... what looks to be a nice piece of certified sustainable ... what you,re getting. Unfortunately, things aren,t always what they seem, ... eco-labeled Chilean sea bass and report their findings in the ... Press publication. "We found that, for fish purchased ...
... AUGUST 22, 2011, 3:00 PM U.S. EASTERN TIME) ... Academy of Sciences (PNAS) documents the success of ... business model to improve rural livelihoods while restoring local ... the program began in Zambia in 2003 and has ...
... of Naval Research (ONR) will share partnership possibilities with ... Annual Navy Gold Coast Small Business Opportunity Conference, being ... allows us to identify potential program participants from among ... Office of Small Business Programs. "The event is a ...
Cached Biology News:Eco-labeled seafood is not always what it seems 2Study confirms food security helps wildlife 2